1. For the diagnosis and risk stratification of
    • structural heart disease (coronary, valvular, myocardial and congenital)
    • arrhythmic heart disorders
    • ion channel syndromes
    • electrolyte alterations
  2. For the planning and control of the therapy of
    • cardiac arrhythmias
    • acute chest pain
    • syncope
    • acute dyspnea
    • palpitations
  3. For the evaluation and programming of implantable devices for
    • cardiac rhythm management
    • cardiac resynchronization therapy
  4. To monitor
    • pharmacological treatments (beta-blockers, calcium antagonists, class I and III antiarrhythmic agents, antidepressants … etc.)
    • severe electrolyte disorders, mainly related to potassium and calcium levels
    • critical patients
  5. For the screening of
    • relatives of patients with familiar forms of heart disorders
    • athletes
    • airplane pilots
    • people obtaining a life-insurance
  6. For epidemiological studies
  7. As a teaching and investigational tool


Last modified: Thursday, 7 June 2018, 12:46 PM
You are currently using guest access (Login)